WHO ICTRP trial
A randomised double-blind placebo-controlled multi-centre clinical study of the…
ITMCTR2025000518 · International Traditional Medicine Clinical Trial Registry (ITMCTR) · Recruiting
Key facts
| Trial ID | ITMCTR2025000518 |
|---|---|
| Public title | A randomised double-blind placebo-controlled multi-centre clinical study of the efficacy and safety of Rupi Sanjie Capsule in the treatment of female breast hyperplasia with thyroid nodules (Liver Depression and Qi Stagnation syndrome). |
| Scientific title | A randomised double-blind placebo-controlled multi-centre clinical study of the efficacy and safety of Rupi Sanjie Capsule in the treatment of female breast hyperplasia with thyroid nodules (Liver Depression and Qi Stagnation syndrome). |
| Primary sponsor | Chongqing Traditional Chinese Medicine Hospital |
| Registry | International Traditional Medicine Clinical Trial Registry (ITMCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | Post-marketing clinical trial |
| Countries | China |
| Conditions | Female breast hyperplasia with thyroid nodules |
| Interventions | Test group:Take Rupisanjie Capsules 4 capsules each time 3 times a day.;Control group:Take the Rupisanjie Capsules placebo, four capsules each time, three times a day. |
| Registration date | Mar 13, 2025 |
| Target size | Test group:30;Control group:30 |
| Registry page | itmctr.ccebtcm.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: